bicyclo(FΦR4-DADAD)Rho

General Information


DRACP ID  DRACP05455

Peptide Name   bicyclo(FΦR4-DADAD)Rho

Sequence  XDADADKRRRRΦFXKX

Sequence Length  16

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Asp2<--->Asp6; Arg8<--->Phe13

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  X(1)=Tm, trimesoyl; Φ=L-2-naphthylalanine; X(14)=L-2,3-diaminopropionic acid; X(16)=Rho, rhodamine B

Chiral  Mix



Physicochemical Information


Formula  C63H100N26O15

Absent amino acids  CEGHILMNPQSTVWY

Common amino acids  R

Mass  205938

Pl  11.48

Basic residues  6

Acidic residues  3

Hydrophobic residues  3

Net charge  3

Boman Index  -9034

Hydrophobicity  -186.88

Aliphatic Index  12.5

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24896852

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  2254

DRACP is developed by Dr.Zheng's team.